Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

INO stock hub

Inovio Pharmaceuticals, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

INOis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

119.6M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

INO

In the news

Latest news · INO

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-183.5

P25 -105.6P50 -46.5P75 -3.1

ROIC-95.3

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All INO market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

211

Groups with data

Currency

USD

Showing 211 of 211 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001055726
Company name	Inovio Pharmaceuticals, Inc.
Country	United States
Country code	US
Cusip	45773H201
Employees	112
Employees Change	-22%
Employees Change Percent	-16.42
Enterprise value	$70.5M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
IPO Date	1998-02-12
Isin	US45773H4092
Last refreshed	2026-05-10
Market cap	$119.6M
Market cap category	Micro-Cap
Price	$1.46
Price currency	USD
Rev Per Employee	583.42x
Sector	Healthcare
Sic	2834
Symbol	INO
Website	https://www.inovio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-71.01%
EV Sales Forward	21.47x
EV/Sales	1,078.69x
FCF yield	-74.33%
P/B ratio	4.18x
P/S ratio	1,830.79x
PS Forward	36.44x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	$-54.1M
Net Income	$-84.9M
Net Income Growth Quarters	1%
Net Income Growth Years	4%
Pretax Margin	-130,000%
Profit Per Employee	$-758,446
ROA	-57.88
Roa5y	-42.34
ROCE	-283.3
ROE	-183.5
Roe5y	-107.8
ROIC	-95.34

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr10y	-34.95%
Cagr15y	-20.23%
Cagr1y	-17.06%
Cagr20y	-19.36%
Cagr3y	-46.96%
Cagr5y	-55.35%
EPS Growth Quarters	14
EPS Growth Years	4
Revenue Growth	-69.99x
Revenue Growth Years	0x
Revenue Growth3 Y	-81.47x
Revenue Growth5 Y	-61.18x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0
Assets	$74.3M
Cash	$58.5M
Current Assets	$61.1M
Current Liabilities	$43.7M
Debt	$9.4M
Debt Equity	$0.39
Equity	$24.1M
Liabilities	$50.2M
Long Term Assets	$13.2M
Long Term Liabilities	$6.5M
Net Cash	$49.1M
Net Cash By Market Cap	$41.08
Net Cash Growth	-40.25%
Net Debt Equity	$-2.04
Tangible Book Value	$24.1M
Tangible Book Value Per Share	$0.35
WACC	11.27

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	1.4
Net Working Capital	$-38.2M
Quick ratio	1.34
Working Capital	$17.5M
Working Capital Turnover	$0

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-72.63%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
10Y total return	-98.64%
1Y total return	-17.05%
200-day SMA	1.86
3Y total return	-85.08%
50-day SMA	1.4
50-day SMA vs 200-day SMA	50under200
5Y total return	-98.22%
All Time High	2,352
All Time High Change	-99.94%
All Time High Date	2000-03-06
All Time Low	1.03
All Time Low Change	41.75%
All Time Low Date	2026-04-10
ATR	0.11
Beta	1.44
Beta1y	1.24
Beta2y	1.51
Ch YTD	-16.09
High	1.79
High52	2.98
High52 Date	2025-09-09
High52ch	-50.99%
Low	1.36
Low52	1.03
Low52 Date	2026-04-10
Low52ch	41.75%
Ma50ch	4.14%
Premarket Change Percent	0.73
Premarket Price	$1.38
Premarket Volume	300,881
Price vs 200-day SMA	-21.51%
RSI	66.32
RSI Monthly	36.77
RSI Weekly	44.99
Sharpe ratio	0.23x
Sortino ratio	0.36
Total Return	-72.63%
Tr YTD	-16.09
Tr15y	-96.63%
Tr1m	39.05%
Tr1w	32.73%
Tr3m	-12.05%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	4
Analyst Count Top	2
Analyst Price Target Top	$9
Analyst Ratings	Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$-0.32
Earnings Revenue Estimate	250,000x
Earnings Revenue Estimate Growth	282.6x
Operating Income	$-86.8M
Operating margin	-132,871.3
Price target	$6.75
Price Target Change	$362
Price Target Change Top	$516

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	81,595,305%
Float Percent	99.58%
Shares Insiders	0.42%
Shares Institutions	39.31%
Shares Out	81,937,825
Shares Qo Q	18.91%
Shares Yo Y	72.63%
Short Float	15.65%
Short Ratio	4.9
Short Shares	15.58

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-92.7M
Average Volume	3,210,393.3x
Bv Per Share	0.35
CAPEX	$-285,698
Ch10y	-98.64
Ch15y	-96.63
Ch1m	39.05
Ch1w	32.73
Ch1y	-17.05
Ch20y	-98.65
Ch3m	-12.05
Ch3y	-85.08
Ch5y	-98.22
Ch6m	-31.13
Change	6.57%
Change From Open	3.91
Close	1.37
Days Gap	2.55
Depreciation Amortization	1,417,913
Dollar Volume	30,671,611.4
Earnings Date	2026-05-13
Earnings Time	amc
EBIT	$-86.8M
EBITDA	$-85.4M
EPS	$-1.81
F Score	0
FCF	$-88.9M
FCF EV Yield	-126.15x
FCF Per Share	$-1.09
Financing CF	53,050,095
Fiscal Year End	December
Founded	1,979
Investing CF	14,039,357
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-12
Last Report Date	2025-12-31
Last Split Date	2024-01-25
Last Split Type	Reverse
Last10k Filing Date	2026-03-12
Ma150	1.79
Ma150ch	-18.39%
Ma20	1.18
Ma20ch	24.26%
Net CF	-21,539,978
Next Earnings Date	2026-05-13
Open	1.41
Optionable	Yes
Position In Range	22.54
Post Close	1.46
Postmarket Change Percent	13.66
Postmarket Price	$1.66
Ppne	9,070,526
Pre Close	1.37
Price Date	2026-05-08
Ptbv Ratio	4.96
Relative Volume	6.54x
Revenue	65,343x
SBC By Revenue	5,747.8x
Share Based Comp	3,755,788
Tr20y	-98.65%
Tr6m	-31.13%
Us State	Pennsylvania
Volume	21,007,953
Z Score	-36.64

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does INO pay a dividend?

Capital-return profile for this ticker.

Performance

INO stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns INO?

Insider, institutional, and short-interest positioning.

Institutional ownership

+39.3%

Float: +99.6% of shares outstanding

Insider ownership

+0.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

INO momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

66.3

Neutral momentum band

Price vs 200-day MA

-21.5%

50/200-day relationship not available

Beta (5Y)

1.44

More volatile than the market

Sharpe ratio

0.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About INO

Hub-level FAQ points readers to the deeper analysis pages.

What is the current INO stock rating?

Inovio Pharmaceuticals, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full INO analysis?

The full report lives at /stocks/INO/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for INO?

The latest report frames INO around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the INO page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.